Free Trial

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Lee Danner & Bass Inc.

UnitedHealth Group logo with Medical background
Remove Ads

Lee Danner & Bass Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,726 shares of the healthcare conglomerate's stock after selling 915 shares during the quarter. Lee Danner & Bass Inc.'s holdings in UnitedHealth Group were worth $5,932,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Antonelli Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $754,000. Semanteon Capital Management LP raised its holdings in shares of UnitedHealth Group by 419.5% during the 4th quarter. Semanteon Capital Management LP now owns 2,452 shares of the healthcare conglomerate's stock worth $1,240,000 after acquiring an additional 1,980 shares during the period. Lowe Brockenbrough & Co. Inc. grew its holdings in shares of UnitedHealth Group by 0.8% in the fourth quarter. Lowe Brockenbrough & Co. Inc. now owns 23,193 shares of the healthcare conglomerate's stock valued at $11,732,000 after purchasing an additional 195 shares during the period. Whittier Trust Co. of Nevada Inc. raised its stake in UnitedHealth Group by 1.6% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 45,088 shares of the healthcare conglomerate's stock worth $22,808,000 after purchasing an additional 729 shares during the period. Finally, Holderness Investments Co. grew its stake in shares of UnitedHealth Group by 3.4% in the 4th quarter. Holderness Investments Co. now owns 10,080 shares of the healthcare conglomerate's stock valued at $5,099,000 after buying an additional 334 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Remove Ads

UnitedHealth Group Stock Down 0.6 %

Shares of UNH stock traded down $2.92 on Tuesday, reaching $513.58. 3,014,727 shares of the stock were exchanged, compared to its average volume of 4,086,166. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The business's 50 day moving average price is $509.71 and its 200 day moving average price is $546.15.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 earnings per share. The firm's revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.64%. UnitedHealth Group's dividend payout ratio is presently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. KeyCorp reissued an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $629.32.

Check Out Our Latest Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads